• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相抑郁症的治疗

The treatment of bipolar depression.

作者信息

Sachs G S, Koslow C L, Ghaemi S N

机构信息

Massachusetts General Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Boston 02114, USA.

出版信息

Bipolar Disord. 2000 Sep;2(3 Pt 2):256-60. doi: 10.1034/j.1399-5618.2000.20306.x.

DOI:10.1034/j.1399-5618.2000.20306.x
PMID:11249803
Abstract

OBJECTIVES

The treatment of the depressed phase of bipolar disorder is understudied and remains a common clinical dilemma for clinicians. Compared to the manic phases, episodes of bipolar depression are more frequent and of longer duration, yet the literature on this problem is minimal. The few methodologically sound studies find that treatment effective for unipolar depression are also efficacious for bipolar depression. However, standard antidepressant agents may cause acute mania or a long-term worsening of bipolar illness. This paper reviews the available literature on the treatment of bipolar depression and offers recommendations for clinical management.

METHODS

A literature search was conducted using keywords 'bipolar disorder', 'depression', 'drug therapy', 'antidepressants', 'lithium', and 'anticonvulsants'.

RESULTS

If effectively treated by lithium, patients are spared the risk of antidepressant-induced mania. If lithium is not sufficient treatment for acute depression, the combination of lithium and a standard antidepressant appears to reduce the risk of affective switch, as well as the induction of a long-term rapid-cycling course. Additionally, tapering antidepressant medication after periods of sustained remission can be beneficial in limiting the risk of affective switch and acceleration of the cycle rate.

CONCLUSIONS

Doctors must be cautious in prescribing antidepressants for bipolar depression. Use of antidepressants alone should be avoided.

摘要

目的

双相情感障碍抑郁发作期的治疗研究较少,仍然是临床医生常见的临床难题。与躁狂发作期相比,双相抑郁发作更为频繁且持续时间更长,但关于这个问题的文献却很少。少数方法学上合理的研究发现,对单相抑郁有效的治疗方法对双相抑郁也有效。然而,标准抗抑郁药可能会引发急性躁狂或导致双相情感障碍病情长期恶化。本文回顾了关于双相抑郁治疗的现有文献,并为临床管理提供建议。

方法

使用关键词“双相情感障碍”“抑郁”“药物治疗”“抗抑郁药”“锂盐”和“抗惊厥药”进行文献检索。

结果

如果用锂盐有效治疗,患者可避免抗抑郁药诱发躁狂的风险。如果锂盐对急性抑郁治疗不足,锂盐与标准抗抑郁药联合使用似乎可降低情感转换风险以及诱发长期快速循环病程的风险。此外,在持续缓解一段时间后逐渐减少抗抑郁药用量,可能有助于降低情感转换风险和加快循环速度。

结论

医生在为双相抑郁患者开抗抑郁药时必须谨慎。应避免单独使用抗抑郁药。

相似文献

1
The treatment of bipolar depression.双相抑郁症的治疗
Bipolar Disord. 2000 Sep;2(3 Pt 2):256-60. doi: 10.1034/j.1399-5618.2000.20306.x.
2
Rational polypharmacy in the bipolar affective disorders.双相情感障碍中的合理联合用药
Epilepsy Res Suppl. 1996;11:153-80.
3
The use of anticonvulsants in the aftermath of mania.躁狂发作后抗惊厥药物的使用。
J Psychopharmacol. 2006 Mar;20(2 Suppl):23-30. doi: 10.1177/1359786806063073.
4
Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.抗抑郁药治疗双相抑郁的急性期:系统评价和荟萃分析。
J Clin Psychiatry. 2011 Feb;72(2):156-67. doi: 10.4088/JCP.09r05385gre. Epub 2010 Oct 5.
5
An analysis of the efficacy of treatments for bipolar depression.双相抑郁症治疗效果分析。
J Clin Psychiatry. 2008;69 Suppl 5:4-8.
6
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.近期关于急性双相抑郁药物治疗的疗效数据是否支持非抗抑郁药为首选治疗药物这一观点?一项概念性综述。
Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16. doi: 10.1007/s00406-005-0591-9. Epub 2005 Aug 4.
7
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).一项横跨欧洲的大型观察性研究(EMBLEM)中从躁狂发作转为抑郁发作的预测因素
J Affect Disord. 2009 Nov;118(1-3):118-23. doi: 10.1016/j.jad.2009.02.007. Epub 2009 Mar 9.
8
[Bipolar disorders--how to recognize and treat them].[双相情感障碍——如何识别与治疗]
MMW Fortschr Med. 2004 May 24;146 Spec No 2:4-6, 8.
9
[Puzzling bipolar disorder].[令人困惑的双相情感障碍]
MMW Fortschr Med. 2005 May 17;147 Spec No 2:32-6.
10
Antidepressants in bipolar disorder: the case for caution.双相情感障碍中使用抗抑郁药:需谨慎对待
Bipolar Disord. 2003 Dec;5(6):421-33. doi: 10.1046/j.1399-5618.2003.00074.x.

引用本文的文献

1
Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders.双相和单相障碍患者用抗抑郁药的自杀行为风险。
J Clin Psychiatry. 2014 Jul;75(7):720-7. doi: 10.4088/JCP.13m08744.
2
Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.奥氮平单药治疗双相I型抑郁症的疗效:一项随机、双盲、安慰剂对照研究。
Psychopharmacology (Berl). 2014 Jul;231(14):2811-8. doi: 10.1007/s00213-014-3453-1. Epub 2014 Jan 31.
3
Evidence-Based Strategies Improve Assessment of Pediatric Bipolar Disorder by Community Practitioners.
循证策略改善社区医生对儿童双相情感障碍的评估。
Prof Psychol Res Pr. 2011 Apr;42(2):121-129. doi: 10.1037/a0022506.
4
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.抗抑郁药反应轨迹与主要抑郁症的定量脑电图 (QEEG) 生物标志物。
J Psychiatr Res. 2010 Jan;44(2):90-8. doi: 10.1016/j.jpsychires.2009.06.006. Epub 2009 Jul 24.
5
Bipolar disorder and mechanisms of action of mood stabilizers.双相情感障碍与心境稳定剂的作用机制。
Brain Res Rev. 2009 Oct;61(2):185-209. doi: 10.1016/j.brainresrev.2009.06.003. Epub 2009 Jun 23.
6
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.糖原合成酶激酶-3是双相情感障碍治疗干预中一个可行的潜在靶点。
Neurosci Biobehav Rev. 2007;31(6):920-31. doi: 10.1016/j.neubiorev.2007.03.002. Epub 2007 Mar 15.
7
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.近期关于急性双相抑郁药物治疗的疗效数据是否支持非抗抑郁药为首选治疗药物这一观点?一项概念性综述。
Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16. doi: 10.1007/s00406-005-0591-9. Epub 2005 Aug 4.
8
[Annual costs of bipolar disorders in Germany].[德国双相情感障碍的年度成本]
Nervenarzt. 2004 Sep;75(9):896-903. doi: 10.1007/s00115-004-1691-x.